These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17147697)

  • 1. Grafting of thrombopoietin-mimetic peptides into cystine knot miniproteins yields high-affinity thrombopoietin antagonists and agonists.
    Krause S; Schmoldt HU; Wentzel A; Ballmaier M; Friedrich K; Kolmar H
    FEBS J; 2007 Jan; 274(1):86-95. PubMed ID: 17147697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
    Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
    Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide agonists of the thrombopoietin receptor.
    Dower WJ; Cwirla SE; Balasubramanian P; Schatz PJ; Baccanari DP; Barrett RW
    Stem Cells; 1998; 16 Suppl 2():21-9. PubMed ID: 11012174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbodies.
    Schmoldt HU; Daneschdar M; Kolmar H; Blind M
    Methods Mol Biol; 2009; 535():361-72. PubMed ID: 19377985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins.
    Kolmar H
    Curr Opin Pharmacol; 2009 Oct; 9(5):608-14. PubMed ID: 19523876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative binding proteins: biological activity and therapeutic potential of cystine-knot miniproteins.
    Kolmar H
    FEBS J; 2008 Jun; 275(11):2684-90. PubMed ID: 18435757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cell differentiation by hNUDC via a Mpl-dependent mechanism in NIH 3T3 cells.
    Zhang YP; Tang YS; Chen XS; Xu P
    Exp Cell Res; 2007 Sep; 313(15):3210-21. PubMed ID: 17658515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered cystine knot miniproteins as potent inhibitors of human mast cell tryptase beta.
    Sommerhoff CP; Avrutina O; Schmoldt HU; Gabrijelcic-Geiger D; Diederichsen U; Kolmar H
    J Mol Biol; 2010 Jan; 395(1):167-75. PubMed ID: 19852971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4 mimetic miniproteins: potent anti-HIV compounds with promising activity as microbicides.
    Van Herrewege Y; Morellato L; Descours A; Aerts L; Michiels J; Heyndrickx L; Martin L; Vanham G
    J Antimicrob Chemother; 2008 Apr; 61(4):818-26. PubMed ID: 18270220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
    Newland A
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine.
    Cwirla SE; Balasubramanian P; Duffin DJ; Wagstrom CR; Gates CM; Singer SC; Davis AM; Tansik RL; Mattheakis LC; Boytos CM; Schatz PJ; Baccanari DP; Wrighton NC; Barrett RW; Dower WJ
    Science; 1997 Jun; 276(5319):1696-9. PubMed ID: 9180079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent agonists of a hematopoietic stem cell cytokine receptor, c-Mpl.
    Tarasova A; Haylock DN; Meagher L; Be CL; White J; Nilsson SK; Andrade J; Cartledge K; Winkler DA
    ChemMedChem; 2013 May; 8(5):763-71. PubMed ID: 23554275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretion expression and activity assay of a novel fusion protein of thrombopoietin and interleukin-6 in Pichia pastoris.
    Zhiyi H; Wenshan L; Wenze Z; Ning D; Chi Z; Kenan Y; Ping W; Qianqian W; Qing Z
    J Biochem; 2007 Jul; 142(1):17-24. PubMed ID: 17517790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of novel non-peptide thrombopoietin mimetics, their species specificity and the activation mechanism of the thrombopoietin receptor.
    Yamane N; Tanaka Y; Ohyabu N; Yamane S; Maekawa K; Ishizaki J; Suzuki R; Itoh T; Takemoto H
    Eur J Pharmacol; 2008 May; 586(1-3):44-51. PubMed ID: 18377892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of thrombopoietin mimetic peptide GW395058 in BALB/c mice and New Zealand white rabbits: evaluation of the potential for thrombopoietin neutralizing antibody production in man.
    de Serres M; Ellis B; Dillberger JE; Rudolph SK; Hutchins JT; Boytos CM; Weigl DL; DePrince RB
    Stem Cells; 1999; 17(4):203-9. PubMed ID: 10437983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL.
    Nishino T; Miyaji K; Ishiwata N; Arai K; Yui M; Asai Y; Nakauchi H; Iwama A
    Exp Hematol; 2009 Nov; 37(11):1364-1377.e4. PubMed ID: 19744539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered cystine-knot miniproteins for diagnostic applications.
    Kolmar H
    Expert Rev Mol Diagn; 2010 Apr; 10(3):361-8. PubMed ID: 20370592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice rendered severely deficient in megakaryocytes through targeted gene deletion of the thrombopoietin receptor c-Mpl have a normal skeletal phenotype.
    Perry MJ; Redding KA; Alexander WS; Tobias JH
    Calcif Tissue Int; 2007 Sep; 81(3):224-31. PubMed ID: 17674074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist.
    Fukushima-Shintani M; Suzuki K; Iwatsuki Y; Abe M; Sugasawa K; Hirayama F; Kawasaki T; Nakahata T
    Eur J Haematol; 2009 Apr; 82(4):247-54. PubMed ID: 19183407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of thrombopoietin in mast cell differentiation.
    Migliaccio AR; Rana RA; Vannucchi AM; Manzoli FA
    Ann N Y Acad Sci; 2007 Jun; 1106():152-74. PubMed ID: 17468237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.